JP2024514203A5 - - Google Patents
Info
- Publication number
- JP2024514203A5 JP2024514203A5 JP2023563211A JP2023563211A JP2024514203A5 JP 2024514203 A5 JP2024514203 A5 JP 2024514203A5 JP 2023563211 A JP2023563211 A JP 2023563211A JP 2023563211 A JP2023563211 A JP 2023563211A JP 2024514203 A5 JP2024514203 A5 JP 2024514203A5
- Authority
- JP
- Japan
- Prior art keywords
- icd
- zeta signaling
- cells
- dap12
- signaling domains
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163174990P | 2021-04-14 | 2021-04-14 | |
| US63/174,990 | 2021-04-14 | ||
| PCT/US2022/024842 WO2022221548A1 (en) | 2021-04-14 | 2022-04-14 | Chimeric antigen receptors to target cd5-positive cancers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024514203A JP2024514203A (ja) | 2024-03-28 |
| JP2024514203A5 true JP2024514203A5 (cg-RX-API-DMAC7.html) | 2025-02-21 |
Family
ID=83640731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023563211A Pending JP2024514203A (ja) | 2021-04-14 | 2022-04-14 | Cd5陽性がんを標的とするキメラ抗原受容体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240189357A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4322992A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024514203A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240007911A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117480187A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022259658A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023021133A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3216557A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL307408A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023012180A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022221548A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4332118A1 (en) * | 2021-04-29 | 2024-03-06 | Korea Research Institute of Bioscience and Biotechnology | Novel anti-cd5 chimeric antigen receptor and immune cell expressing same |
| CA3233096A1 (en) * | 2021-10-20 | 2023-04-17 | Board Of Regents, The University Of Texas System | Engineering nk cells with a car construct with optimal signaling |
| EP4419541A4 (en) * | 2021-10-21 | 2025-12-17 | Univ Texas | METHOD FOR PRODUCING THERAPEUTIC IMMUNE CELLS WITH IMPROVED METABOLIC FITNESS AND COMPOSITIONS THEREOFUL |
| AU2024280012A1 (en) * | 2023-06-02 | 2025-12-11 | Board Of Regents, The University Of Texas System | Selection of cryopreserved cord blood units for the manufacture of natural killer cells with enhanced potency |
| WO2025038813A1 (en) * | 2023-08-16 | 2025-02-20 | Beam Therapeutics Inc. | Cd5-binding polypeptides, compositions comprising the same, and methods for use thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2977106A1 (en) * | 2015-02-27 | 2016-09-01 | Icell Gene Therapeutics Llc | Chimeric antigen receptors (cars) targeting hematologic malignancies, compositions and methods of use thereof |
| MA41962A (fr) * | 2015-04-23 | 2018-02-28 | Baylor College Medicine | Récepteur antigénique chimérique ciblant le cd5 pour une thérapie adoptive à base de cellules t |
| AU2016274989A1 (en) * | 2015-06-12 | 2017-11-02 | Immunomedics, Inc. | Disease therapy with chimeric antigen receptor (car) constructs and t cells (car-t) or nk cells (car-nk) expressing car constructs |
| US20180371052A1 (en) * | 2015-12-22 | 2018-12-27 | Icell Gene Therapeutics Llc | Chimeric antigen receptors and enhancement of anti-tumor activity |
| CN110475857B (zh) * | 2017-01-05 | 2023-07-18 | 韩国生命工学研究院 | 表达抗-可替宁嵌合抗原受体的天然杀伤细胞 |
| US20230159618A1 (en) * | 2017-07-25 | 2023-05-25 | Board Of Regents, The University Of Texas System | Enhanced chimeric antigen receptors and use thereof |
| TW201908335A (zh) * | 2017-07-25 | 2019-03-01 | 美國德州系統大學評議委員會 | 增強之嵌合抗原受體及其用途 |
-
2022
- 2022-04-14 US US18/552,727 patent/US20240189357A1/en active Pending
- 2022-04-14 JP JP2023563211A patent/JP2024514203A/ja active Pending
- 2022-04-14 BR BR112023021133A patent/BR112023021133A2/pt unknown
- 2022-04-14 MX MX2023012180A patent/MX2023012180A/es unknown
- 2022-04-14 IL IL307408A patent/IL307408A/en unknown
- 2022-04-14 CA CA3216557A patent/CA3216557A1/en active Pending
- 2022-04-14 WO PCT/US2022/024842 patent/WO2022221548A1/en not_active Ceased
- 2022-04-14 CN CN202280042176.6A patent/CN117480187A/zh active Pending
- 2022-04-14 KR KR1020237039102A patent/KR20240007911A/ko active Pending
- 2022-04-14 EP EP22788946.6A patent/EP4322992A4/en active Pending
- 2022-04-14 AU AU2022259658A patent/AU2022259658A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ghasemi et al. | Cytokine-armed dendritic cell progenitors for antigen-agnostic cancer immunotherapy | |
| US20220370501A1 (en) | Methods for enhancing efficacy of therapeutic immune cells | |
| JP7258364B2 (ja) | がんおよび関連悪性腫瘍の治療のためのγδT細胞を活性化、修飾、および増殖させる方法 | |
| JP2024138280A5 (cg-RX-API-DMAC7.html) | ||
| Bontkes et al. | Dendritic cells transfected with interleukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxic T cells | |
| JP2024521185A5 (cg-RX-API-DMAC7.html) | ||
| JP2018500944A5 (cg-RX-API-DMAC7.html) | ||
| Murad et al. | Manufacturing development and clinical production of NKG2D chimeric antigen receptor–expressing T cells for autologous adoptive cell therapy | |
| JP2023539361A5 (cg-RX-API-DMAC7.html) | ||
| JP2022550899A5 (cg-RX-API-DMAC7.html) | ||
| JP2018522567A5 (cg-RX-API-DMAC7.html) | ||
| EP2614151B1 (en) | Interleukin 15 as selectable marker for gene transfer in lymphocytes | |
| JP7572700B2 (ja) | 改変ヒト初代血液樹状細胞株を生成するための方法 | |
| JP2017512484A5 (cg-RX-API-DMAC7.html) | ||
| JP2024525609A5 (cg-RX-API-DMAC7.html) | ||
| JP2021525534A5 (cg-RX-API-DMAC7.html) | ||
| CN107847585A (zh) | 用于得到体内存留性和治疗活性的nkt细胞亚群以及其繁殖 | |
| Schaft et al. | T cell re-targeting to EBV antigens following TCR gene transfer: CD28-containing receptors mediate enhanced antigen-specific IFNγ production | |
| JP2024527879A5 (cg-RX-API-DMAC7.html) | ||
| Yu et al. | Revolution of CAR engineering for next-generation immunotherapy in solid tumors | |
| Lv et al. | γδT cells, a key subset of T cell for cancer immunotherapy | |
| JP2022513164A5 (cg-RX-API-DMAC7.html) | ||
| Dörrie et al. | Introduction of functional chimeric E/L-selectin by RNA electroporation to target dendritic cells from blood to lymph nodes | |
| JP2022513099A5 (cg-RX-API-DMAC7.html) | ||
| EP4423121A1 (en) | Methods for culturing cells expressing c-jun |